Last data update: Sep 18, 2023 . (Total: 1932 publications since 2020)
Records 1-30 (of 1031 Records) |
Query Trace: Transmission[original query] |
---|
Point Prevalence Estimates of Activity-Limiting Long-Term Symptoms among U.S. Adults ≥1 Month After Reported SARS-CoV-2 Infection, November 1, 2021.
Tenforde MW , Devine OJ , Reese HE , Silk BJ , Iuliano AD , Threlkel R , Vu QM , Plumb ID , Cadwell BL , Rose C , Steele MK , Briggs-Hagen M , Ayoubkhani D , Pawelek P , Nafilyan V , Saydah SH , Bertolli J . J Infect Dis 2023 227 (7) 855-863 ![]() ![]() ![]() ![]() |
Protection of 2 and 3 mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized with COVID-19 - VISION Network, August 2021 - March 2022.
DeSilva MB , Mitchell PK , Klein NP , Dixon BE , Tenforde MW , Thompson MG , Naleway AL , Grannis SJ , Ong TC , Natarajan K , Reese SE , Zerbo O , Kharbanda AB , Patel P , Stenehjem E , Raiyani C , Irving SA , Fadel WF , Rao S , Han J , Reynolds S , Davis JM , Lewis N , McEvoy C , Dickerson M , Dascomb K , Valvi NR , Barron MA , Goddard K , Vazquez-Benitez G , Grisel N , Mamawala M , Embi PJ , Fireman B , Essien IJ , Griggs EP , Arndorfer J , Gaglani M . J Infect Dis 2023 227 (8) 961-969 ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Relative effectiveness of COVID-19 vaccination and booster dose combinations among 18.9 million vaccinated adults during the early SARS-CoV-2 Omicron period - United States, January 1, 2022-March 31, 2022
Kompaniyets L , Wiegand RE , Oyalowo AC , Bull-Otterson L , Egwuogu H , Thompson T , Kahihikolo K , Moore L , Jones-Jack N , El Kalach R , Srinivasan A , Messer A , Pilishvili T , Harris AM , Gundlapalli AV , Link-Gelles R , Boehmer TK . Clin Infect Dis 2023 76 (10) 1753-1760 ![]() ![]() ![]() ![]() |
Pediatric Infection-Induced SARS-CoV-2 Seroprevalence Increases and Seroprevalence by Type of Clinical Care-September 2021-February 2022.
Clarke KEN , Kim Y , Jones J , Lee A , Deng Y , Nycz E , Iachan R , Gundlapalli AV , MacNeil A , Hall A . J Infect Dis 2023 227 (3) 364-370 ![]() ![]() ![]() ![]() ![]() |
Association of culturable-virus detection and household transmission of SARS-CoV-2 - California and Tennessee, 2020-2022
Deyoe JE , Kelly JD , Grijalva CG , Bonenfant G , Lu S , Anglin K , Garcia-Knight M , Pineda-Ramirez J , Hagen MB , Saydah S , Abedi GR , Goldberg SA , Tassetto M , Zhang A , Donohue KC , Davidson MC , Sanchez RD , Djomaleu M , Mathur S , Shak JR , Deeks SG , Peluso MJ , Chiu CY , Zhu Y , Halasa NB , Chappell JD , Mellis A , Reed C , Andino R , Martin JN , Zhou B , Talbot HK , Midgley CM , Rolfes MA . J Infect Dis 2023 227 (12) 1343-1347 ![]() ![]() ![]() ![]() ![]() ![]() |
Severe Fatigue and Persistent Symptoms at Three Months Following SARS-CoV-2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study.
Gottlieb M , Wang RC , Yu H , Spatz ES , Montoy JCC , Rodriguez RM , Chang AM , Elmore JG , Hannikainen PA , Hill M , Huebinger RM , Idris AH , Lin Z , Koo K , McDonald S , O'Laughlin KN , Plumb ID , Santangelo M , Saydah S , Willis M , Wisk LE , Venkatesh A , Stephens KA , Weinstein RA . Clin Infect Dis 2023 76 (11) 1930-1941 ![]() ![]() ![]() ![]() ![]() ![]() |
Cyclospora cayetanensis comprises at least three species that cause human cyclosporiasis
Barratt JLN , Shen J , Houghton K , Richins T , Sapp SGH , Cama V , Arrowood MJ , Straily A , Qvarnstrom Y . Parasitology 2023 150 (3) 269-285 ![]() ![]() ![]() |
SARS-CoV-2 infection history and antibody response to three COVID-19 mRNA vaccine doses.
Herring MK , Romine JK , Wesley MG , Ellingson KD , Yoon SK , Caban-Martinez AJ , Meece J , Gaglani M , Grant L , Olsho LEW , Tyner HL , Naleway AL , Khan SM , Phillips AL , Solle NS , Rose S , Mak J , Fuller SB , Hunt A , Kuntz JL , Beitel S , Yoo YM , Zheng PQ , Arani G , Lamberte JM , Edwards T , Thompson MG , Sprissler R , Thornburg NJ , Lowe AA , Pilishvili T , Uhrlaub JL , Lutrick K , Burgess JL , Fowlkes AL . Clin Infect Dis 2023 76 (10) 1822-1831 ![]() ![]() ![]() ![]() ![]() |
Meeting report: 35th international conference on antiviral research in Seattle, WA, USA - March 21-25, 2022.
Spengler JR , Welch SR , Deval J , Gentry BG , Brancale A , Carter K , Moffat J , Meier C , Seley-Radtke KL , Schang LM . Antiviral Res 2023 211 105521 ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Characteristics of Nursing Home Residents and Healthcare Personnel with Repeat Positive SARS-CoV-2 Tests ≥ 90 Days After Initial Infection: 4 U.S. Jurisdictions, July 2020 - March 2021.
Wilson WW , Hatfield KM , Tressler S , BickingKinsey C , Parra G , Zell R , Denson A , Williams C , Spicer KB , Kamal-Ahmed I , Abdalhamid B , Gemechu M , Folster J , Thornburg NJ , Tamin A , Harcourt JL , Queen K , Tong S , Jernigan JA , Crist M , Perkins KM , Reddy SC . Infect Control Hosp Epidemiol 2023 44 (5) 809-812 ![]() ![]() ![]() ![]() |
Occupations Associated with SARS-CoV-2 Infection and Vaccination, U.S. Blood Donors, July 2021-December 2021.
Shah MM , Spencer BR , Feldstein LR , Haynes JM , Benoit TJ , Saydah SH , Groenewold MR , Stramer SL , Jones JM . Clin Infect Dis 2023 76 (7) 1285-1294 ![]() ![]() ![]() ![]() ![]() ![]() |
Three-month symptom profiles among symptomatic adults with positive and negative SARS-CoV-2 tests: a prospective cohort study from the INSPIRE group.
Spatz ES , Gottlieb M , Wisk LE , Anderson J , Chang AM , Gentile NL , Hill MJ , Huebinger RM , Idris AH , Kinsman J , Koo K , Li SX , McDonald S , Plumb ID , Rodriguez RM , Saydah S , Slovis B , Stephens KA , Unger ER , Wang RC , Yu H , Hota B , Elmore JG , Weinstein RA , Venkatesh A . Clin Infect Dis 2023 76 (9) 1559-1566 ![]() ![]() ![]() ![]() |
Pfizer-BioNTech COVID-19 vaccine effectiveness against SARS-CoV-2 infection among long-term care facility staff with and without prior infection in New York City, January-June 2021.
Peebles K , Arciuolo RJ , Romano AS , Sell J , Greene SK , Lim S , Mulready-Ward C , Ternier A , Badenhop B , Blaney K , Real JE , Spencer M , McPherson TD , Ahuja SD , SullivanMeissner J , Zucker JR , Rosen JB . J Infect Dis 2023 227 (4) 533-542 ![]() ![]() ![]() ![]() ![]() |
NFKB2 haploinsufficiency identified via screening for IFNα2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complications.
Bodansky A , Vazquez SE , Chou J , Novak T , Al-Musa A , Young C , Newhams M , Kucukak S , Zambrano LD , Mitchell A , Wang CY , Moffitt K , Halasa NB , Loftis LL , Schwartz SP , Walker TC , Mack EH , Fitzgerald JC , Gertz SJ , Rowan CM , Irby K , Sanders RC Jr , Kong M , Schuster JE , Staat MA , Zinter MS , Cvijanovich NZ , Tarquinio KM , Coates BM , Flori HR , Dahmer MK , Crandall H , Cullimore ML , Levy ER , Chatani B , Nofziger R , Geha RS , DeRisi J , Campbell AP , Anderson M , Randolph AG . J Allergy Clin Immunol 2023 151 (4) 926-930.e2 ![]() ![]() ![]() |
Early detection of SARS-CoV-2 variants using traveler-based genomic surveillance at four US airports, September 2021- January 2022.
Wegrzyn RD , Appiah GD , Morfino R , Milford SR , Walker AT , Ernst ET , Darrow WW , Li SL , Robison K , MacCannell D , Dai D , Girinathan BP , Hicks AL , Cosca B , Woronoff G , Plocik AM , Simen BB , Moriarty L , Guagliardo SAJ , Cetron MS , Friedman CR . Clin Infect Dis 2023 76 (3) e540-e543 ![]() ![]() ![]() ![]() ![]() |
Use of Serial Testing to Interrupt a SARS-CoV-2 Outbreak on a Hospital Medical Floor - Minnesota, October-December 2020.
Prabhu RM , Firestone MJ , Bergman KL , Beaudoin AL , Hale T , Lorentz AJ , Garfin J , Wang X , Holzbauer SM . Infect Control Hosp Epidemiol 2023 44 (3) 427-432 ![]() ![]() ![]() |
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.
Link-Gelles R , Ciesla AA , Roper LE , Scobie HM , Ali AR , Miller JD , Wiegand RE , Accorsi EK , Verani JR , Shang N , Derado G , Britton A , Smith ZR , Fleming-Dutra KE . MMWR Morb Mortal Wkly Rep 2023 72 (5) 119-124 ![]() ![]() ![]() ![]() ![]() |
Effectiveness of first and second COVID-19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021-July 2022.
Petrie JG , King JP , McClure DL , Rolfes MA , Meece JK , Pattinson D , Neumann G , Kawaoka Y , Belongia EA , McLean HQ . Influenza Other Respir Viruses 2023 17 (3) e13104 ![]() ![]() ![]() ![]() |
Respiratory virus circulation during the first year of the COVID-19 pandemic in the Household Influenza Vaccine Evaluation (HIVE) cohort
Fine SR , Bazzi LA , Callear AP , Petrie JG , Malosh RE , Foster-Tucker JE , Smith M , Ibiebele J , McDermott A , Rolfes MA , Monto AS , Martin ET . Influenza Other Respir Viruses 2023 17 (3) e13106 ![]() ![]() ![]() ![]() |
Bacterial and viral infections among adults hospitalized with COVID-19, COVID-NET, 14 states, March 2020-April 2022
Shah MM , Patel K , Milucky J , Taylor CA , Reingold A , Armistead I , Meek J , Anderson EJ , Weigel A , Reeg L , Como-Sabetti K , Ropp SL , Muse A , Bushey S , Shiltz E , Sutton M , Talbot HK , Chatelain R , Havers FP . Influenza Other Respir Viruses 2023 17 (3) e13107 ![]() ![]() ![]() ![]() |
Relationship between telework experience and presenteeism during COVID-19 pandemic, United States, March-November 2020
Shafer L , Ahmed F , Kim S , Wernli KJ , Jackson ML , Nowalk MP , Bear T , Zimmerman RK , Martin ET , Monto AS , Gaglani M , Reis M , Chung JR , Flannery B , Uzicanin A . Emerg Infect Dis 2023 29 (2) 278-285 ![]() ![]() ![]() ![]() ![]() |
Isolating the effect of COVID-19-related disruptions on HIV diagnoses in the United States in 2020
Viguerie A , Song R , Johnson AS , Lyles CM , Hernandez A , Farnham PG . J Acquir Immune Defic Syndr 2023 92 (4) 293-299 ![]() ![]() ![]() |
Increase in Colorado tick fever virus disease cases and effect of COVID-19 pandemic on behaviors and testing practices, Montana, 2020
Soto RA , Baldry E , Vahey GM , Lehman J , Silver M , Panella A , Brault AC , Hughes HR , Fitzpatrick KA , Velez J , Biggerstaff BJ , Wolff B , Randolph J , Ruth LJ , Staples JE , Gould CV . Emerg Infect Dis 2023 29 (3) 561-568 ![]() ![]() ![]() ![]() |
Protection from COVID-19 mRNA vaccination and prior SARS-CoV-2 infection against COVID-19-associated encounters in adults during Delta and Omicron predominance.
Bozio CH , Butterfield KA , BriggsHagen M , Grannis S , Drawz P , Hartmann E , Ong TC , Fireman B , Natarajan K , Dascomb K , Gaglani M , DeSilva MB , Yang DH , Midgley CM , Dixon BE , Naleway AL , Grisel N , Liao IC , Reese SE , Fadel WF , Irving SA , Lewis N , Arndorfer J , Murthy K , Riddles J , Valvi NR , Mamawala M , Embi PJ , Thompson MG , Stenehjem E . J Infect Dis 2023 ![]() ![]() ![]() ![]() ![]() |
Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization.
Feikin DR , Higdon MM , Andrews N , Collie S , DeloriaKnoll M , Kwong JC , Link-Gelles R , Pilishvili T , Patel MK . Vaccine 2023 ![]() ![]() ![]() ![]() |
Preliminary estimates of effectiveness of monovalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection among children aged 3-5 years - increasing community access to testing program, United States, July 2022-February 2023
Fleming-Dutra KE , Ciesla AA , Roper LE , Smith ZR , Miller JD , Accorsi EK , Verani JR , Shang N , Derado G , Wiegand RE , Pilishvili T , Britton A , Link-Gelles R . MMWR Morb Mortal Wkly Rep 2023 72 (7) 177-182 ![]() ![]() ![]() ![]() |
COVID-19 vaccination coverage and demographic characteristics of infants and children aged 6 months-4 years - United States, June 20-December 31, 2022
Murthy BP , Fast HE , Zell E , Murthy N , Meng L , Shaw L , Vogt T , Chatham-Stephens K , Santibanez TA , Gibbs-Scharf L , Harris LQ . MMWR Morb Mortal Wkly Rep 2023 72 (7) 183-189 ![]() ![]() ![]() |
Reporting rates for VAERS death reports following COVID-19 vaccination, December 14, 2020-November 17, 2021
Day B , Menschik D , Thompson D , Jankosky C , Su J , Moro P , Zinderman C , Welsh K , Dimova RB , Nair N . Pharmacoepidemiol Drug Saf 2023 ![]() ![]() ![]() |
When to update COVID-19 vaccine composition.
Grant R , Sacks JA , Abraham P , Chunsuttiwat S , Cohen C , Figueroa JP , Fleming T , Fine P , Goldblatt D , Hasegawa H , MacIntrye CR , Memish ZA , Miller E , Nishioka S , Sall AA , Sow S , Tomori O , Wang Y , VanKerkhove MD , Wambo MA , Cohen HA , Mesfin S , Otieno JR , Subissi L , Briand S , Wentworth DE , Subbarao K . Nat Med 2023 ![]() ![]() ![]() ![]() ![]() |
COVID-19 vaccine reactogenicity and vaccine attitudes among children and parents/guardians after multisystem inflammatory syndrome in children or COVID-19 hospitalization: September 2021-May 2022
Yousaf AR , Kunkel A , Abrams JY , Shah AB , Hammett TA , Arnold KE , Beltran YL , Laham FR , Kao CM , Hunstad DA , Hussaini L , Baida N , Salazar L , Perez MA , Rostad CA , Godfred-Cato S , Campbell AP , Belay ED . Pediatr Infect Dis J 2023 42 (3) 252-259 ![]() ![]() ![]() ![]() ![]() |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: